BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Antiviral agents
1
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
1/21/2022 8:16:14 AM | Browse: 610 | Download: 1406
2
Prediction models for the development of hepatocellular carcinoma in chronic hepatitis B patients
4/29/2021 8:35:47 AM | Browse: 504 | Download: 1078
3
M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
6/6/2020 2:43:56 PM | Browse: 1243 | Download: 2582
4
Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions
8/7/2019 7:09:17 AM | Browse: 1191 | Download: 2046
5
Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
6/27/2019 10:40:37 AM | Browse: 1148 | Download: 1868
6
3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy
1/12/2017 1:49:00 PM | Browse: 1122 | Download: 2840
7
Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America
6/2/2016 3:32:00 PM | Browse: 1101 | Download: 1581
8
Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon
1/20/2016 5:04:00 PM | Browse: 1288 | Download: 1821
9
Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment
1/15/2016 9:49:00 AM | Browse: 1170 | Download: 1883
10
Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a “special population”?
8/8/2015 1:55:00 PM | Browse: 1329 | Download: 2355
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345